- Elanco Provides Innovation Update
- Elanco to Participate in Goldman Sachs 45th Annual Global Healthcare Conference
- Elanco Announces FDA Has Completed Review of Bovaer®, First-in-Class Methane-Reducing Feed Ingredient, for U.S. Dairy Industry
- Elanco to Participate in Stifel 2024 Jaws and Paws Conference
- Elanco Animal Health Reports First Quarter 2024 Results
- Elanco's 'Parvo is Poop' Campaign Unleashes Awareness and Action on National Parvo Awareness Day
- Elanco Confirms Date and Conference Call for First Quarter 2024 Financial Results Announcement
More ▼
Key statistics
On Friday, Elanco Animal Health Inc (ELAN:NYQ) closed at 14.22, -24.36% below its 52-week high of 18.80, set on Jun 12, 2024.
52-week range
Short selling activityProvided by S&P Global Market Intelligence
Open | 14.08 |
---|---|
High | 14.28 |
Low | 13.83 |
Bid | 13.69 |
Offer | 14.49 |
Previous close | 14.13 |
Average volume | 8.69m |
---|---|
Shares outstanding | 494.18m |
Free float | 490.93m |
P/E (TTM) | -- |
Market cap | 7.03bn USD |
EPS (TTM) | -2.64 USD |
Data delayed at least 15 minutes, as of Jul 06 2024 00:00 BST.
More ▼